USPTO serial 79351364
Serial No. 79351364
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 26, 2023
- Examiner
- KHAN, AHSEN M
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79351364?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Govinda M. Davis
Govinda M. Davis Dinsmore & Shohl LLP255 E Fifth Street, Suite 1900Cincinnati, OH 45202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; biological preparations for use in cell cultures in the field of biotechnology, other than medical use; biochemicals for in vitro and in vivo scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; catalysts for use in biochemical processes; biochemical catalysts; catalysts for chemical and biochemical processes; chemical additives for use in the manufacture of cosmetics; buffer solutions for use in analytical chemistry; reagents for chemical analyses; reagents for use in scientific apparatus for chemical or biological analysis; cultures of microorganisms, other than for medical and veterinary use for scientific or laboratory purposes and for character change for scientific or laboratory purposes; biological preparations, other than for medical or veterinary purposes, for character change for scientific or laboratory purposes; biological preparation for use in cell cultures other than for medical or veterinary use | ACTIVE | — |
| 005 | Biological preparations for medical purposes for the treatment of cancer and prevention of viruses; biopharmaceuticals preparations for the treatment of cancer and prevention of viruses; biopharmaceutical preparations for treating infectious disease; [ pharmaceutical preparations for the treatment of cancer and prevention of viruses; ] chemical preparations for pharmaceutical purposes for the treatment of cancer and prevention of viruses; pills for pharmaceutical purposes for the treatment of cancer and prevention of viruses; chemico-pharmaceutical preparations for the treatment of cancer and prevention of viruses; biotechnological preparations for medical use. namely, pharmaceutical preparations for the treatment of cancer and prevention of viruses; medicines for human purposes for the treatment of cancer and prevention of viruses; pharmaceutical preparations for the treatment of cancer and prevention of viruses; viral vaccines; human vaccine preparations; veterinary vaccines; human immune globulin sold as a pharmaceutical preparation for the treatment of cancer and prevention of viruses; biosimilar pharmaceutical preparations for the treatment of cancer and prevention of viruses; pharmaceutical preparations for immunity adjustment; biopharmaceuticals for the treatment of cancer | ACTIVE | — |
| 009 | Laboratory equipment, namely, incubators for cell culture; bioreactor for cell culturing; disposable plastic bioreactors for cell culture; cell culture apparatus for laboratory use, namely, cell culture dishes, scaffolds, well plates, flasks, microscopes; bioreactors for laboratory use; bioreactors for research use; fast liquid chromatography columns for laboratory use; fast liquid chromatography apparatus for laboratory use; laboratory chemical reactors; chemistry apparatus and instruments, namely, sensors analyzing diseased cells and monitoring reagents; apparatus and instruments for physics, namely, sensors for measuring cell activity, movement, growth and stress; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 035 | Business administration; retail store services featuring biopharmaceuticals; business intermediary services relating to the purchase and sale of biopharmaceuticals, namely, providing sales leads for the biopharmaceutical industry; sales agency services for biopharmaceuticals, namely, telephone and online order-taking services for others; sales arranging of biopharmaceuticals, namely, telephone and online order-taking services for others; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; business intermediary services relating to the purchase and sale of pharmaceuticals namely, providing sales leads for the pharmaceutical industry; sales agency services for pharmaceuticals, namely, telephone and online order-taking services for others; sales arranging of pharmaceuticals, namely, telephone and online order-taking services for others | ACTIVE | — |
| 040 | Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials, namely, processing of biopharmaceutical materials; processing of medical products, namely, chemical processing of pharmaceuticals; custom manufacture of pharmaceuticals; processing of chemicals; chemical processing of medicinal materials | ACTIVE | — |
| 042 | Biotechnology research; advisory services relating to biotechnology, namely, technological research relating to pharmaceutical manufacturing process technology; research and development of technology for biotechnology; consulting in the field of biotechnology, namely, providing consultation, advice, and information in the field of engineering research; laboratory research in the field of biology; research and development of biopharmaceuticals; consulting services relating to biopharmaceuticals product development; research and development of vaccines and medicines; drug discovery services; pharmaceutical drug development for the treatment of viral and infectious diseases, for the treatment of cancer; development of pharmaceutical preparations and medicines; clinical research in the field of medicine; development of biologics; design of biologics; research of biologics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PRESTIGE BIOPHARMA KOREA CO., LTD
- Other trademarks owned by PRESTIGE BIOPHARMA KOREA CO., LTD
- Other trademarks owned by PRESTIGE BIOPHARMA KOREA CO., LTD
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 2, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Nov 14, 2025 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Nov 13, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Nov 13, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 28, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 15, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 26, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 26, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 26, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 26, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 26, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 10, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 10, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 10, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 20, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 1, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 6, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 6, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 26, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 25, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |